CUPR
Cuprina Holdings (Cayman) Ltd.
NASDAQ · Healthcare · Biotechnology · SG
$1.80
−2.17%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.19x
- Price / sales
- 255.37x
- Price / cash flow
- -0.99x
Enterprise value
- Enterprise value
- $10.6M
- EV / sales
- 213.71x
- EV / EBITDA
- -2.18x
- EV / EBIT
- -2.17x
- Market cap
- $12.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025